CANY
CADX

Caxton Associates (New York)’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Caxton Associates (New York)’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-75,000
Closed -$679K – 282
2013
Q4 		$679K Buy
+75,000
New +$679K 0.02% 144